Lince Sabrina L, van Kempen Leon C, Dijkstra Jeroen R, IntHout Joanna, Vierhout Mark E, Kluivers Kirsten B
Department of Obstetrics and Gynecology (791), Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands,
Int Urogynecol J. 2014 Sep;25(9):1237-42. doi: 10.1007/s00192-014-2385-y. Epub 2014 Apr 24.
The rs1800255, COL3A1 2209 G>A polymorphism in the alpha 1 chain of collagen type III has been associated with an increased risk of pelvic organ prolapse (POP). In one of our previous studies however, polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) misdiagnosed rs1800255, COL3A1 2209 G>A in 6 % of cases. The high-resolution melting (HRM) analysis on the contrary obtained a 100 % accordance for this specific polymorphism and was used in the present study to validate this risk factor for POP.
In this case-control study, women with and without symptoms of POP were included and compared. DNA was extracted from blood samples. HRM analysis was used to assess for the presence of the homozygous rs1800255. Groups were compared using the Pearson chi-square, Mann-Whitney, and t tests. The discrepancy between HRM and PCR-RFLP results was investigated using PCR-RFLP results available from our previous study.
The study included 354 women: 272 patients with POP and 82 controls; 18 (7 %) cases versus 3 (4 %) controls had a homozygous rs1800255, COL3A1 2209 G>A polymorphism (odds ratio 1.9, 95 % confidence interval 0.5-6.9, compared to the wild type), and thus no association between POP and the homozygous polymorphism could be demonstrated. A discrepancy between HRM and PCR-RFLP results was found in 8 % of the samples.
The previously found statistically significant association between the rs1800255, COL3A1 2209 G>A polymorphism as measured with PCR-RFLP and POP could no longer be demonstrated. This raises concerns regarding the results of other association studies using PCR-RFLP.
III型胶原蛋白α1链中的rs1800255、COL3A1 2209G>A多态性与盆腔器官脱垂(POP)风险增加有关。然而,在我们之前的一项研究中,基于聚合酶链反应的限制性片段长度多态性(PCR-RFLP)在6%的病例中误诊了rs1800255、COL3A1 2209G>A。相反,高分辨率熔解(HRM)分析对该特定多态性的检测符合率为100%,本研究采用该方法来验证POP的这一风险因素。
在这项病例对照研究中,纳入了有和没有POP症状的女性并进行比较。从血样中提取DNA。采用HRM分析评估纯合子rs1800255的存在情况。使用Pearson卡方检验、Mann-Whitney检验和t检验对各组进行比较。利用我们之前研究中可得的PCR-RFLP结果,对HRM和PCR-RFLP结果之间的差异进行了研究。
该研究纳入了354名女性:272例POP患者和82名对照;18例(7%)病例与3例(4%)对照存在纯合子rs1800255、COL3A1 2209G>A多态性(与野生型相比,优势比为1.9,95%置信区间为0.5 - 6.9),因此无法证明POP与纯合子多态性之间存在关联。在8%的样本中发现了HRM和PCR-RFLP结果之间的差异。
先前通过PCR-RFLP检测发现的rs1800255、COL3A1 2209G>A多态性与POP之间具有统计学意义的关联不再成立。这引发了对其他使用PCR-RFLP的关联研究结果的担忧。